Search results
Dec 8, 2023 · CRSP stock surged on the news, and is up nearly 50% year to date. CRSP stock sank 8.1% to close at 64.54. Crispr has been trading around a 72 cup-base buy point. VRTX stock dipped 1.1% to close at ...
Under Subscriptions, select CRSP. Under Quarterly Update, select Stock/Security Files > Monthly Stock File (or Daily Stock File ). Fill out the Web Query Form (see detailed instructions ). Step 1: Enter a date range. Step 2: Enter company codes, upload a .txt file, or search the entire database (this takes a while). Step 3: Select query variables.
First-Ever Approved CRISPR-Based Therapy. CASGEVY™ (exagamglogene autotemcel), a CRISPR/Cas9 gene-edited therapy arising out of our collaboration with Vertex Pharmaceuticals Incorporated, is approved in some countries for certain eligible patients with sickle cell disease or transfusion-dependent beta thalassemia. Learn more.
52 Week Low 37.55. 52 Week Low Date 10/23/23. Market Cap 4.949B. Shares Out 84.92M. 10 Day Average Volume 1.06M. Dividend -. Dividend Yield -. Beta 1.70. YTD % Change -6.91.
CRSP. Real time quote. About CRISPR Therapeutics AG. CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases ...
20 hours ago · Stock analysis for CRISPR Therapeutics AG (CRSP:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Survivor-Bias-Free Mutual Funds database serves as a foundation for research in and benchmarking for this asset class. CRSP-Compustat Merged database allows for concurrent database access to CRSP’s stock data and Compustat’s fundamental data. Ziman Real Estate database merges CRSP indices creation with the Ziman Center’s expertise in ...
